Akut Renal Kolikli Hastalarda Dilaltı Piroksikam ve İntranazal Dezmopressin Kombine Tedavisinin Etkisi
Yükleniyor...
Dosyalar
Tarih
2009
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
İnönü Üniversitesi Tıp Fakültesi Dergisi
Erişim Hakkı
Attribution 3.0 United States
Özet
Dezmopressin sentetik antidiüretik hormon (ADH) analoğudur. ADH ile karşılaştırıldığında antidiüretik etkisi daha fazla ve uzundur. Son yıllarda akut renal kolik ağrısının tedavisinde kullanılmaktadır. Bu çalışmada akut renal kolik ağrılı hastalarda dilaltı piroksikam ve intranasal dezmopressin kombine tedavisinin etkisi değerlendirildi.
Materyal-Metot: Çalışmaya 45 renal kolikli hasta dahil edildi. Hastalar randomize olarak 3 gruba ayrıldı. İlk gruba (n=15) 40 µg intranazal dezmopressin sprey, 2. gruba 40 mg dilaltı piroksikam ve 3. gruba ise 40 mg dilaltı piroksikama ek 40 µg intranazal dezmopressin verildi. Hastaların ağrı şiddeti görsel anolog skala (VAS) kullanılarak 0 ile 10 arasında derecelendirildi.
Bulgular: Tedaviden 10 ve 20 dakika sonra ortalama ağrı skoru grup 3’de diğer gruplara göre daha düşüktü ve grup 1 ile 2 arasında anlamlı fark yoktu. Tedaviden 30 dakika sonra ortalama ağrı skoru grup 1’de diğer gruplara göre daha yüksekti ve grup 2 ile 3 arasında anlamlı fark yoktu. Tedavi sonrası ek tedavi ihtiyacı (intramusküler 50 mg pethidin) grup 3’de anlamlı derecede daha düşüktü (sırasıyla; %59.1, %27.3 ve %13.6).
Sonuç: Bizim sonuçlarımız akut renal kolikli hastaların ağrısının dindirilmesinde piroksikam ve intranazal dezmopressin kombine tedavisinin etkili olduğunu gösterdi.
Desmopressin is a synthetic antidiuretic hormone (ADH) analogue. When it is compared to ADH, the anti-diuretic effect is more and longer. In recent years it is used to relieve pain in patients with acute renal colic. In the present study we evaluated the effect of combined therapy of intranasal desmopressin spray and sublingual piroxicam in patients with acute renal colic. Materials and Methods: Forty-five patients with renal colic included into the study. Patients were randomized into 3 groups. The first group (n=15) received 40 µg intranasal desmopressin spray, the second group (n=15) 40 mg sublingual piroxicam and the third group (n=15) received 40 µg intranasal desmopressin spray in addition to 40 mg sublingual piroxicam. To evaluate the intensity of pain, visual analogue scale (VAS) was used and the patients were asked to grade the pain ranging from 0-10. Results: Mean pain scores 10 and 20 minutes after the treatment was lower in group 3 when compared to the other groups and there was not any significant difference between group 1 and 2. Mean pain scores 30 minutes after the treatment in group 1 was significantly higher when compared to other groups and there was not any significant difference in groups 2 and 3. Need for additional treatment (intramuscular 50 mg pethidin) was significantly lower in group 3 (59.1%, 27.3% and 13.6% respectively). Conclusion: Our data demonstrated that combined therapy of sublingual piroxicam and intranasal desmopressin was effective to relieve pain in patients with acute renal colic.
Desmopressin is a synthetic antidiuretic hormone (ADH) analogue. When it is compared to ADH, the anti-diuretic effect is more and longer. In recent years it is used to relieve pain in patients with acute renal colic. In the present study we evaluated the effect of combined therapy of intranasal desmopressin spray and sublingual piroxicam in patients with acute renal colic. Materials and Methods: Forty-five patients with renal colic included into the study. Patients were randomized into 3 groups. The first group (n=15) received 40 µg intranasal desmopressin spray, the second group (n=15) 40 mg sublingual piroxicam and the third group (n=15) received 40 µg intranasal desmopressin spray in addition to 40 mg sublingual piroxicam. To evaluate the intensity of pain, visual analogue scale (VAS) was used and the patients were asked to grade the pain ranging from 0-10. Results: Mean pain scores 10 and 20 minutes after the treatment was lower in group 3 when compared to the other groups and there was not any significant difference between group 1 and 2. Mean pain scores 30 minutes after the treatment in group 1 was significantly higher when compared to other groups and there was not any significant difference in groups 2 and 3. Need for additional treatment (intramuscular 50 mg pethidin) was significantly lower in group 3 (59.1%, 27.3% and 13.6% respectively). Conclusion: Our data demonstrated that combined therapy of sublingual piroxicam and intranasal desmopressin was effective to relieve pain in patients with acute renal colic.
Açıklama
İnönü Üniversitesi Tıp Fakültesi Dergisi 16 (1) 29-32 (2009)
Anahtar Kelimeler
Dezmopressin, Piroksikam, Akut Renal Kolik, Desmopressin, Piroxicam, Acute Renal Colic
Kaynak
WoS Q Değeri
Scopus Q Değeri
Cilt
Sayı
Künye
Özden, Cüneyt ;Gökkaya, Cevdet Serkan ;Günay, İsa ;Demirdal, Özgür ;Özdal, Özdem Levent ;Memiş, Ali ;(2009) Akut Renal Kolikli Hastalarda Dilaltı Piroksikam ve İntranazal Dezmopressin Kombine Tedavisinin Etkisi,İnönü Üniversitesi Tıp Fakültesi Dergisi.
